Kintor Pharmaceutical Limited (KNTPF)
OTCMKTS
· Delayed Price · Currency is USD
0.1774
-0.0315 (-15.08%)
At close: Apr 7, 2025
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of $77.00 million as of May 27, 2025. Its market cap has increased by 47.38% in one year.
Market Cap
77.00M
Enterprise Value
74.87M
Revenue
685.02K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 1.02B to 77.00M, a decrease of -92.48%. That is a compound annual growth rate of -40.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 27, 2025 | 77.00M | 42.42% |
Dec 31, 2024 | 54.07M | -42.09% |
Dec 29, 2023 | 93.37M | -83.48% |
Dec 30, 2022 | 565.31M | -7.54% |
Dec 31, 2021 | 611.38M | 22.68% |
Dec 31, 2020 | 498.34M | -51.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.63B |
Veradigm | 747.23M |
Nika Pharmaceuticals | 672.83M |
Tian'an Technology Group | 591.73M |
Elite Pharmaceuticals | 565.54M |
Glass House Brands | 452.21M |
CytoDyn | 423.89M |
Northwest Biotherapeutics | 399.83M |